144 related articles for article (PubMed ID: 9377618)
1. Lansoprazole compared with histamine2-receptor antagonists in healing gastric ulcers: a meta-analysis.
Tunis SR; Sheinhait IA; Schmid CH; Bishop DJ; Ross SD
Clin Ther; 1997; 19(4):743-57. PubMed ID: 9377618
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Poynard T; Lemaire M; Agostini H
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
[TBL] [Abstract][Full Text] [Related]
3. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.
Agrawal NM; Campbell DR; Safdi MA; Lukasik NL; Huang B; Haber MM
Arch Intern Med; 2000 May; 160(10):1455-61. PubMed ID: 10826458
[TBL] [Abstract][Full Text] [Related]
4. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
5. Gastric ulcer healing and basic fibroblast growth factor: effects of lansoprazole and famotidine.
Tsuji S; Kawano S; Higashi T; Mukuda T; Imaizumi T; Tatsumi T; Miura N; Miyajima K; Fukuda M; Noguchi M
J Clin Gastroenterol; 1995; 20 Suppl 2():S1-4. PubMed ID: 7594320
[TBL] [Abstract][Full Text] [Related]
6. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.
Spencer CM; Faulds D
Drugs; 1994 Sep; 48(3):404-30. PubMed ID: 7527761
[TBL] [Abstract][Full Text] [Related]
7. Effect of lansoprazole on peptic ulcers.
Ohashi T; Sakata J; Haraguchi Y; Eto T
J Clin Gastroenterol; 1995; 20 Suppl 2():S83-5. PubMed ID: 7594350
[TBL] [Abstract][Full Text] [Related]
8. Comparison of lansoprazole and famotidine for gastric ulcer by endoscopic ultrasonography: a preliminary trial.
Okai T; Sawabu N; Songür Y; Motoo Y; Watanabe H
J Clin Gastroenterol; 1995; 20 Suppl 2():S32-5. PubMed ID: 7594335
[TBL] [Abstract][Full Text] [Related]
9. Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer?
Okai T; Ohtsubo K; Sakai J; Watanabe H; Motoo Y; Kawashima A; Sawabu N
Can J Gastroenterol; 2000 Oct; 14(9):761-6. PubMed ID: 11064311
[TBL] [Abstract][Full Text] [Related]
10. The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers.
Sasakii M; Joh T; Yokoyama Y; Seno K; Tsuchida K; Kurokawa T; Itoh M
J Pharm Pharmacol; 1999 Jul; 51(7):825-30. PubMed ID: 10467958
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of lansoprazole on peptic ulcers in elderly patients.
Murakami M; Saita H; Takahashi Y; Kusaka S; Asagoe K; Dekigai H; Matsumoto M; Seki M; Mizuno M; Maeda S
J Clin Gastroenterol; 1995; 20 Suppl 2():S79-82. PubMed ID: 7594348
[TBL] [Abstract][Full Text] [Related]
12. Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection.
Spinzi GC; Bierti L; Bortoli A; Colombo E; Fertitta AM; Lanzi GL; Venturelli R; Minoli G
Aliment Pharmacol Ther; 1998 May; 12(5):433-8. PubMed ID: 9663722
[TBL] [Abstract][Full Text] [Related]
13. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
Ogawa N
Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent eradication of Helicobacter pylori with dual therapy.
Treiber G; Ammon S; Klotz U
Aliment Pharmacol Ther; 1997 Aug; 11(4):711-8. PubMed ID: 9305480
[TBL] [Abstract][Full Text] [Related]
15. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
Sakaguchi M; Ashida K; Umegaki E; Miyoshi H; Katsu K
J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of lansoprazole in eradication of Helicobacter pylori.
Katoh M; Asaka M; Kudoh M; Kagaya H; Katagiri M; Takeda H
J Clin Gastroenterol; 1995; 20 Suppl 2():S112-4. PubMed ID: 7594324
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of gastric ulcer healing by lansoprazole by measurement of ulcer diameter.
Aoyama N; Kinoshita Y; Misaki F; Himeno S; Kasuga M; Chiba T
J Clin Gastroenterol; 1995; 20 Suppl 2():S86-9. PubMed ID: 7594351
[TBL] [Abstract][Full Text] [Related]
18. Peptic ulcer therapy with lansoprazole and Helicobacter pylori eradication.
Ogoshi K; Kato T; Sakagawa T
J Clin Gastroenterol; 1995; 20 Suppl 2():S97-9. PubMed ID: 7594354
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers.
Arkkila PE; Seppälä K; Kosunen TU; Sipponen P; Mäkinen J; Rautelin H; Färkkilä M
Eur J Gastroenterol Hepatol; 2005 Jan; 17(1):93-101. PubMed ID: 15647648
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic ultrasonographic evaluation of gastric ulcer healing on treatment with proton pump inhibitors versus H2-receptor antagonists.
Tanaka M; Maruoka A; Chijiiwa Y; Tanaka M; Nawata H
Scand J Gastroenterol; 1994 Dec; 29(12):1140-4. PubMed ID: 7886404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
